AMITMED (奥达智声)
Bei Jing Shi, China
Since its establishment, the company has focused on providing robot-based system for minimally invasive cancer treatments. The new generation robot-based soft tissue puncture system developed by AMIT is mainly used for minimally invasive percutaneous interventional ablations for liver cancers, which helps doctors to provide accurate treatment and improve patients' prognosis, especially for early-stage cancer patients. This system will fill the gap in the field of minimally invasive treatment product and method for liver cancer and meet the current unmet need for liver cancer treatment in China.
Company Info
- Founded
- 2021
- Website
- www.amit.net.cn/
Only accessible to MedStartr community members.
Join nowWhat do you think of AMITMED (奥达智声)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.